Skip to main content

$0.021 -0.001 (-4.55%)

High

$0.02

Low

$0.02

Trades

21

Turnover

$7,224

Volume

342,066
30 June 2023 at 3:53pm
Register to track EPN and receive email alerts.

Clinical Trial Supply Agreement with MCRI

StockBot

416,823 posts

EPN released this announcement to the ASX on 9 June 2021, 9:06. The announcement is marked as price sensitive, and is 2 page(s) in length and 256.63kb in size.

You can view all announcements from EPN and see how they appear on a price chart on the announcements page.

At the date of this announcement, EPN was 0.011% short sold according to ASIC data. It was ranked the 573rd most shorted stock on the ASX. It remains ranked 603rd as of the latest reported data (05 June 2023).

Other Recent Announcements from EPN
Results of Meeting 31 May 2023, 13:53
Chief Executive Officer Appointment 19 May 2023, 9:58
Medicinal Cannabis Permit Renewed 12 May 2023, 10:06
Clinical Trial Supply Agreement with MCRI 9 June 2021, 9:06
Appointment of Divisional Manager of Cannabis Operations 1 June 2021, 9:30
Over $1m R&D Tax Incentive Received 26 May 2021, 9:33
Change of Company Address 11 May 2021, 18:32
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EPN and receive email alerts.